BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 25240616)

  • 21. Anticancer activities of novel chalcone and bis-chalcone derivatives.
    Modzelewska A; Pettit C; Achanta G; Davidson NE; Huang P; Khan SR
    Bioorg Med Chem; 2006 May; 14(10):3491-5. PubMed ID: 16434201
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mild C(sp
    Romo-Pérez A; Miranda LD; Chávez-Blanco AD; Dueñas-González A; Camacho-Corona MDR; Acosta-Huerta A; García A
    Eur J Med Chem; 2017 Sep; 138():1-12. PubMed ID: 28641156
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Anti-breast cancer activity of heteroaryl chalcone derivatives.
    Solomon VR; Lee H
    Biomed Pharmacother; 2012 Apr; 66(3):213-20. PubMed ID: 22440895
    [TBL] [Abstract][Full Text] [Related]  

  • 24. 2-Hydroxychalcone and xanthohumol inhibit invasion of triple negative breast cancer cells.
    Kim SY; Lee IS; Moon A
    Chem Biol Interact; 2013 May; 203(3):565-72. PubMed ID: 23562496
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Synthesis, antitumor and antibacterial activities of some novel tetrahydrobenzo[4,5]thieno[2,3-d]pyrimidine derivatives.
    Abbas SE; Abdel Gawad NM; George RF; Akar YA
    Eur J Med Chem; 2013 Jul; 65():195-204. PubMed ID: 23708013
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Design, synthesis and systematic evaluation of cytotoxic 3-heteroarylisoquinolinamines as topoisomerases inhibitors.
    My Van HT; Woo H; Jeong HM; Khadka DB; Yang SH; Zhao C; Jin Y; Lee ES; Youl Lee K; Kwon Y; Cho WJ
    Eur J Med Chem; 2014 Jul; 82():181-94. PubMed ID: 24904965
    [TBL] [Abstract][Full Text] [Related]  

  • 27. 7-Substituted umbelliferone derivatives as androgen receptor antagonists for the potential treatment of prostate and breast cancer.
    Kandil S; Westwell AD; McGuigan C
    Bioorg Med Chem Lett; 2016 Apr; 26(8):2000-4. PubMed ID: 26965862
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Synthesis of 2-alkoxy and 2-benzyloxy analogues of estradiol as anti-breast cancer agents through microtubule stabilization.
    Sathish Kumar B; Kumar A; Singh J; Hasanain M; Singh A; Fatima K; Yadav DK; Shukla V; Luqman S; Khan F; Chanda D; Sarkar J; Konwar R; Dwivedi A; Negi AS
    Eur J Med Chem; 2014 Oct; 86():740-51. PubMed ID: 25238172
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Synthesis, antitumor evaluation and docking study of novel 4-anilinoquinazoline derivatives as potential epidermal growth factor receptor (EGFR) inhibitors.
    Rao GW; Xu GJ; Wang J; Jiang XL; Li HB
    ChemMedChem; 2013 Jun; 8(6):928-33. PubMed ID: 23640754
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hydrogen sulfide-releasing aspirin suppresses NF-κB signaling in estrogen receptor negative breast cancer cells in vitro and in vivo.
    Chattopadhyay M; Kodela R; Nath N; Barsegian A; Boring D; Kashfi K
    Biochem Pharmacol; 2012 Mar; 83(6):723-32. PubMed ID: 22209867
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cytotoxicity and gene expression profiles of novel synthesized steroid derivatives as chemotherapeutic anti-breast cancer agents.
    Elmegeed GA; Khalil WK; Mohareb RM; Ahmed HH; Abd-Elhalim MM; Elsayed GH
    Bioorg Med Chem; 2011 Nov; 19(22):6860-72. PubMed ID: 22000946
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Synthesis of novel β-carboline based chalcones with high cytotoxic activity against breast cancer cells.
    Chauhan SS; Singh AK; Meena S; Lohani M; Singh A; Arya RK; Cheruvu SH; Sarkar J; Gayen JR; Datta D; Chauhan PM
    Bioorg Med Chem Lett; 2014 Jul; 24(13):2820-4. PubMed ID: 24844196
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Design and synthesis of novel 2'-hydroxy group substituted 2-pyridone derivatives as anticancer agents.
    Lv Z; Zhang Y; Zhang M; Chen H; Sun Z; Geng D; Niu C; Li K
    Eur J Med Chem; 2013 Sep; 67():447-53. PubMed ID: 23920246
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Synthesis of novel benzo[4,5]thiazolo[1,2-a]pyrimidine-3-carboxylate derivatives and biological evaluation as potential anticancer agents.
    Nagarapu L; Vanaparthi S; Bantu R; Ganesh Kumar C
    Eur J Med Chem; 2013 Nov; 69():817-22. PubMed ID: 24113366
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Design, synthesis, cytocidal activity and estrogen receptor α affinity of doxorubicin conjugates at 16α-position of estrogen for site-specific treatment of estrogen receptor positive breast cancer.
    Saha P; Fortin S; Leblanc V; Parent S; Asselin É; Bérubé G
    Steroids; 2012 Sep; 77(11):1113-22. PubMed ID: 22801351
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Antiproliferative activity of some 1,4-dimethylcarbazoles on cells that express estrogen receptors: part I.
    Caruso A; Chimento A; El-Kashef H; Lancelot JC; Panno A; Pezzi V; Saturnino C; Sinicropi MS; Sirianni R; Rault S
    J Enzyme Inhib Med Chem; 2012 Aug; 27(4):609-13. PubMed ID: 21883039
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Characterization of lovastatin-docosahexaenoate anticancer properties against breast cancer cells.
    Siddiqui RA; Harvey KA; Xu Z; Natarajan SK; Davisson VJ
    Bioorg Med Chem; 2014 Mar; 22(6):1899-908. PubMed ID: 24556504
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Novel R-(+)-limonene-based thiosemicarbazones and their antitumor activity against human tumor cell lines.
    Vandresen F; Falzirolli H; Almeida Batista SA; da Silva-Giardini AP; de Oliveira DN; Catharino RR; Ruiz AL; de Carvalho JE; Foglio MA; da Silva CC
    Eur J Med Chem; 2014 May; 79():110-6. PubMed ID: 24727464
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Chemistry of Ecteinascidins. Part 5: An Additional Proof of Cytotoxicity Evaluation of Ecteinascidin 770 Derivatives.
    Toyoshima R; Mori N; Suzuki T; Lowtangkitcharoen W; Suwanborirux K; Saito N
    Chem Pharm Bull (Tokyo); 2016; 64(7):966-9. PubMed ID: 27373655
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Synthesis and cytotoxicity of (+/-)-7,9-dideoxy-pancratistatin analogues.
    Nieto-García O; Alonso R
    Org Biomol Chem; 2013 Jan; 11(3):515-22. PubMed ID: 23207545
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.